Plumbagin inhibits growth of gliomas in vivo via suppression of FOXM1 expression

by Mingshan Niu, Wei Cai, Huize Liu, Yulong Chong, Wenqiang Hu, Shangfeng Gao, Qiong Shi, Xiuping Zhou, Xuejiao Liu, Rutong Yu
Published 2015-07-01

CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways

by Xuejiao Liu, Yulong Chong, Yiming Tu, Ning Liu, Chenglong Yue, Zhenglei Qi, Huize Liu, Yao Yao, Hongmei Liu, Shangfeng Gao, Mingshan Niu, Rutong Yu
Published 2016-10-01

SWAP-70 promotes glioblastoma cellular migration and invasion by regulating the expression of CD44s

by Lin Shi, Huize Liu, Yifeng Wang, Yulong Chong, Jie Wang, Guanzheng Liu, Xu Zhang, Xiangyu Chen, Huan Li, Mingshan Niu, Jun Liang, Rutong Yu, Xuejiao Liu
Published 2019-11-01

Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway

by Xuejiao Liu, Yiming Tu, Yifeng Wang, Di Zhou, Yulong Chong, Lin Shi, Guanzheng Liu, Xu Zhang, Sijin Wu, Huan Li, Shangfeng Gao, Mingshan Niu, Rutong Yu
Published 2020-03-01